GB9118204D0
(en)
*
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
KR100223616B1
(en)
*
|
1993-07-31 |
1999-10-15 |
웨스톤 테렌스 에드워드 |
Needleless injector
|
US5478316A
(en)
*
|
1994-02-02 |
1995-12-26 |
Becton, Dickinson And Company |
Automatic self-injection device
|
FR2718357B1
(en)
*
|
1994-04-06 |
1997-10-03 |
Defarges Alain Moreau |
Improvements made to a needleless jet injection device.
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
DE19526984A1
(en)
*
|
1995-07-25 |
1997-01-30 |
Jenapharm Gmbh |
Pharmaceutical preparation for the treatment of erectile dysfunction
|
FR2739562B1
(en)
*
|
1995-10-09 |
1998-04-24 |
Moreau Defarges Alain |
JET INJECTION DEVICE WITHOUT NEEDLE, INCLUDING AN OVER-MOLDED CARTRIDGE
|
US5836911A
(en)
*
|
1996-02-01 |
1998-11-17 |
Medi-Ject Corporation |
Injection device having positioning means
|
US5651772A
(en)
*
|
1996-02-28 |
1997-07-29 |
Aeroquip Corporation |
Needle guard assembly
|
US5817069A
(en)
*
|
1996-02-28 |
1998-10-06 |
Vadus, Inc. |
Valve assembly
|
US5697917A
(en)
|
1996-02-29 |
1997-12-16 |
Medi-Ject Corporation |
Nozzle assembly with adjustable plunger travel gap
|
US5643211A
(en)
|
1996-02-29 |
1997-07-01 |
Medi-Ject Corporation |
Nozzle assembly having a frangible plunger
|
US5722953A
(en)
|
1996-02-29 |
1998-03-03 |
Medi-Ject Corporation |
Nozzle assembly for injection device
|
US5865795A
(en)
|
1996-02-29 |
1999-02-02 |
Medi-Ject Corporation |
Safety mechanism for injection devices
|
US5800388A
(en)
|
1996-02-29 |
1998-09-01 |
Medi-Ject Corporation |
Plunger/ram assembly adapted for a fluid injector
|
US5921967A
(en)
|
1996-02-29 |
1999-07-13 |
Medi-Ject Corporation |
Plunger for nozzle assembly
|
US5782802A
(en)
*
|
1996-03-22 |
1998-07-21 |
Vitajet Corporation |
Multiple use needle-less hypodermic injection device for individual users
|
US5725503A
(en)
*
|
1996-08-07 |
1998-03-10 |
Aeroquip Corporation |
Ratcheting needle protector assembly
|
CA2261938C
(en)
*
|
1996-08-07 |
2004-07-13 |
Vadus, Inc. |
Needle protector
|
US5709662A
(en)
*
|
1996-08-23 |
1998-01-20 |
Becton Dickinson France, S.A. |
Cartridge for an injection device
|
US5875976A
(en)
|
1996-12-24 |
1999-03-02 |
Medi-Ject Corporation |
Locking mechanism for nozzle assembly
|
US6080137A
(en)
*
|
1997-01-08 |
2000-06-27 |
Vadus, Inc. |
Needle protector
|
US5954698A
(en)
*
|
1997-01-08 |
1999-09-21 |
Vadus, Inc. |
Catheter apparatus having valved catheter hub and needle protector
|
US6607509B2
(en)
*
|
1997-12-31 |
2003-08-19 |
Medtronic Minimed, Inc. |
Insertion device for an insertion set and method of using the same
|
US5938637A
(en)
*
|
1997-03-14 |
1999-08-17 |
Path |
Single-use medicine delivery unit for needleless hypodermic injector
|
US6610042B2
(en)
|
1997-12-05 |
2003-08-26 |
Felton Medical, Inc. |
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
|
KR100622160B1
(en)
*
|
1998-07-27 |
2006-09-07 |
안타레스 팔마, 인코퍼레이티드 |
Injection-assisting probe for medical injector assembly
|
US6264629B1
(en)
*
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
FR2796289B1
(en)
*
|
1999-07-16 |
2001-08-10 |
Cross Site Technologies |
NEEDLELESS SYRINGE WITH SUPERIMPOSED ELEMENT INJECTOR
|
US6102896A
(en)
*
|
1999-09-08 |
2000-08-15 |
Cambridge Biostability Limited |
Disposable injector device
|
US6224567B1
(en)
*
|
1999-09-08 |
2001-05-01 |
Cambridge Biostability Limited |
Modified disposable injector device
|
US6802826B1
(en)
|
1999-10-11 |
2004-10-12 |
Felton International, Inc. |
Universal anti-infectious protector for needleless injectors
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US6776776B2
(en)
*
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US20020198509A1
(en)
*
|
1999-10-14 |
2002-12-26 |
Mikszta John A. |
Intradermal delivery of vaccines and gene therapeutic agents via microcannula
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
DE19955201A1
(en)
*
|
1999-11-16 |
2001-05-31 |
Roesch Ag Medizintechnik |
Injection device
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
US6558348B2
(en)
*
|
2000-04-07 |
2003-05-06 |
Equidyne Systems, Inc. |
Low cost disposable needleless injector system for variable and fixed dose applications
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
US6602222B1
(en)
|
2000-10-13 |
2003-08-05 |
Cambridge Biostability Ltd. |
Disposable injection device
|
CA2324045A1
(en)
*
|
2000-10-20 |
2002-04-20 |
Universite De Sherbrooke |
No-needle syringe for the subcutaneous injection of medicated powders
|
EP2269639B1
(en)
|
2001-02-23 |
2018-11-28 |
GlaxoSmithKline Biologicals s.a. |
Influenza vaccine formulations for intradermal delivery
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
US7615234B2
(en)
|
2001-09-11 |
2009-11-10 |
Glide Pharmaceutical Technologies Limited |
Drug delivery technology
|
GB2404865B
(en)
|
2001-09-11 |
2005-09-28 |
Caretek Medical Ltd |
Novel drug delivery technology
|
GB2391480B
(en)
|
2002-08-05 |
2007-02-28 |
Caretek Medical Ltd |
Drug delivery system
|
EP1476210B1
(en)
|
2002-02-11 |
2008-09-24 |
Antares Pharma, Inc. |
Intradermal injector
|
US6676630B2
(en)
|
2002-06-04 |
2004-01-13 |
Bioject Medical Technologies, Inc. |
Needle-free injection system
|
US6883222B2
(en)
*
|
2002-10-16 |
2005-04-26 |
Bioject Inc. |
Drug cartridge assembly and method of manufacture
|
US7252651B2
(en)
*
|
2003-01-07 |
2007-08-07 |
Becton, Dickinson And Company |
Disposable injection device
|
AU2004272972A1
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
WO2005034949A1
(en)
*
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
US7442182B2
(en)
*
|
2003-10-24 |
2008-10-28 |
Bioject, Inc. |
Spring powered needle-free injection system
|
US20050209554A1
(en)
*
|
2004-03-19 |
2005-09-22 |
Sergio Landau |
Needle-free single-use cartridge and injection system
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
GB0414054D0
(en)
|
2004-06-23 |
2004-07-28 |
Owen Mumford Ltd |
Improvements relating to automatic injection devices
|
ES2540770T3
(en)
|
2004-09-22 |
2015-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition for use in staphylococcal vaccination
|
US20060089593A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Sergio Landau |
Needle-free injection device for individual users
|
US20060089594A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Sergio Landau |
Needle-free injection device
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
EP2532378B1
(en)
|
2004-12-01 |
2016-04-27 |
AcuShot, Inc. |
Needle-free injector
|
JP5216328B2
(en)
|
2005-01-24 |
2013-06-19 |
アンタレス ファーマ インコーポレイテッド |
Pre-filled needle assist syringe jet injector
|
GB2422784A
(en)
|
2005-02-07 |
2006-08-09 |
Caretek Medical Ltd |
Disposable assembly comprising a needle or stylet
|
AU2006226543B2
(en)
|
2005-03-23 |
2011-10-06 |
Glaxosmithkline Biologicals S.A. |
Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
|
ES2614086T3
(en)
|
2005-04-04 |
2017-05-29 |
University Of Florida Research Foundation, Inc. |
Desferritiocin polyether analogs
|
US7314462B2
(en)
*
|
2005-04-12 |
2008-01-01 |
Span-America Medical Systems, Inc. |
Passive needle-stick protector
|
EP1919504B1
(en)
*
|
2005-08-03 |
2013-10-16 |
iBio, Inc. |
Antibody to bacillus anthracis protective antigen
|
US20070055199A1
(en)
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Drug delivery device for buccal and aural applications and other areas of the body difficult to access
|
US7842008B2
(en)
*
|
2005-11-21 |
2010-11-30 |
Becton, Dickinson And Company |
Intradermal delivery device
|
CA2669764C
(en)
*
|
2005-12-07 |
2013-05-07 |
Painless Tech Gmbh |
Injection apparatus and ampoule unit
|
TWI457133B
(en)
*
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
Novel composition
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CN101378778B
(en)
|
2005-12-22 |
2013-02-06 |
葛兰素史密丝克莱恩生物有限公司 |
Vaccine comprising streptococcus pneumoniae capsular polyaccharide conjugates
|
DE102005062206B3
(en)
*
|
2005-12-24 |
2006-12-14 |
Lts Lohmann Therapie-Systeme Ag |
Disposable injection syringe has comprises piston and cylinder unit filled with active material and spring unit comprising coil spring held in compressed state by band which is cut before syringe is used by blade at its top
|
US20080161755A1
(en)
*
|
2006-01-27 |
2008-07-03 |
Bioject Inc. |
Needle-free injection device and priming system
|
CA2640177A1
(en)
|
2006-01-31 |
2007-08-09 |
Novo Nordisk A/S |
Seal for a prefilled medical jet injection device
|
WO2008048344A2
(en)
*
|
2006-02-13 |
2008-04-24 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
EP1984405A4
(en)
*
|
2006-02-13 |
2010-06-30 |
Fraunhofer Usa Inc |
Influenza antigens, vaccine compositions, and related methods
|
CA2642056A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Hpv antigens, vaccine compositions, and related methods
|
WO2007106415A2
(en)
*
|
2006-03-10 |
2007-09-20 |
Massachusetts Institute Of Technology |
Triggered self-assembly conjugates and nanosystems
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
EA015833B1
(en)
|
2006-03-30 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Immunogenic composition
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
WO2007120638A2
(en)
*
|
2006-04-12 |
2007-10-25 |
President And Fellows Of Harvard College |
Methods and compositions for modulating glycosylation
|
US8251947B2
(en)
|
2006-05-03 |
2012-08-28 |
Antares Pharma, Inc. |
Two-stage reconstituting injector
|
WO2007133807A2
(en)
|
2006-05-15 |
2007-11-22 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
EP2492684B1
(en)
|
2006-06-02 |
2016-12-28 |
President and Fellows of Harvard College |
Protein surface remodeling
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
CA2651992A1
(en)
|
2006-06-30 |
2008-01-10 |
Abbott Biotechnology Ltd. |
Automatic injection device
|
DK2043682T3
(en)
|
2006-07-17 |
2014-06-02 |
Glaxosmithkline Biolog Sa |
INFLUENZA VACCINE
|
US9115358B2
(en)
*
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
US20100061990A1
(en)
*
|
2006-08-14 |
2010-03-11 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
JO3598B1
(en)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
Boronic acids and esters as inhibitors of fatty acid amide hydrolase
|
BRPI0717219B8
(en)
|
2006-10-12 |
2021-05-25 |
Glaxosmithkline Biologicals Sa |
immunogenic composition, and, use of an immunogenic composition
|
SI2086582T1
(en)
|
2006-10-12 |
2013-02-28 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
BRPI0719756A2
(en)
|
2006-12-01 |
2014-01-21 |
Anterios Inc |
Amphiphilic Nanoparticles
|
US20080213377A1
(en)
*
|
2006-12-08 |
2008-09-04 |
Bhatia Sangeeta N |
Delivery of Nanoparticles and/or Agents to Cells
|
DK2474525T3
(en)
|
2006-12-26 |
2020-07-13 |
Lantheus Medical Imaging Inc |
Ligands for imaging cardiac innervation
|
DE102007004211A1
(en)
*
|
2007-01-27 |
2008-07-31 |
Lts Lohmann Therapie-Systeme Ag |
Disposable injector with at least one towing hook
|
ES2558928T3
(en)
|
2007-01-31 |
2016-02-09 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
DE102007008369A1
(en)
|
2007-02-16 |
2008-08-21 |
Lts Lohmann Therapie-Systeme Ag |
Disposable injector with at least one central tie rod
|
WO2008103997A2
(en)
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Needle-free injection devices and drug delivery systems therefor
|
JP5439193B2
(en)
|
2007-03-15 |
2014-03-12 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. |
Desferrithiocin polyether analogue
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
KR101623985B1
(en)
|
2007-03-28 |
2016-05-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Stitched polypeptides
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
US8778348B2
(en)
*
|
2007-04-28 |
2014-07-15 |
Ibio Inc. |
Trypanosoma antigens, vaccine compositions, and related methods
|
JP2010529166A
(en)
*
|
2007-06-14 |
2010-08-26 |
クルセル スウィツァーランド アーゲー |
Intradermal influenza vaccine
|
US8524444B2
(en)
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
JP2010531330A
(en)
|
2007-06-26 |
2010-09-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Vaccine containing Streptococcus pneumoniae capsular polysaccharide conjugate
|
EP2178558B1
(en)
|
2007-07-11 |
2014-04-30 |
iBio, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
US20110059130A1
(en)
*
|
2007-08-20 |
2011-03-10 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
|
EP2205074A4
(en)
*
|
2007-10-04 |
2013-07-31 |
Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP3424525A1
(en)
|
2007-10-12 |
2019-01-09 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
US9533098B2
(en)
|
2007-11-19 |
2017-01-03 |
Painless Tech Gmbh |
Injection device for the needle-free injection of a medium
|
CN101951927A
(en)
*
|
2008-01-03 |
2011-01-19 |
麻省理工学院 |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
TW201000107A
(en)
*
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
MX2010011412A
(en)
|
2008-04-16 |
2010-11-12 |
Glaxosmithkline Biolog Sa |
Vaccine.
|
JP2011523353A
(en)
*
|
2008-04-28 |
2011-08-11 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
Overcharged protein for cell penetration
|
US20110212157A1
(en)
|
2008-06-26 |
2011-09-01 |
Anterios, Inc. |
Dermal delivery
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
CA2734991A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Massachusetts Institute Of Technology |
Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
Ligation of stapled polypeptides
|
ES2738539T3
(en)
|
2008-08-05 |
2020-01-23 |
Antares Pharma Inc |
Multi dose injector
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
WO2010077806A1
(en)
|
2008-12-15 |
2010-07-08 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
CN105132387A
(en)
*
|
2008-12-22 |
2015-12-09 |
绿光生物科学公司 |
Compositions and methods for the production of a compound
|
WO2010108116A1
(en)
|
2009-03-20 |
2010-09-23 |
Antares Pharma, Inc. |
Hazardous agent injection system
|
WO2010118155A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
WO2010118159A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
WO2010129023A2
(en)
|
2009-04-28 |
2010-11-11 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
AU2013204406B2
(en)
*
|
2009-04-29 |
2015-07-09 |
Abbvie Biotechnology Ltd |
Automatic injection device
|
BRPI1012162A2
(en)
*
|
2009-04-29 |
2016-01-12 |
Abbott Biotech Ltd |
automatic injection device
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
JP2012528858A
(en)
|
2009-06-01 |
2012-11-15 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
O-GlcNAc transferase inhibitor and use thereof
|
US9163330B2
(en)
|
2009-07-13 |
2015-10-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
WO2011014704A2
(en)
|
2009-07-30 |
2011-02-03 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
US9480801B2
(en)
*
|
2009-08-21 |
2016-11-01 |
Becton Dickinson France |
Tamper evident tip cap and syringe
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2011041391A1
(en)
|
2009-09-29 |
2011-04-07 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
TWI619521B
(en)
|
2009-12-15 |
2018-04-01 |
艾伯維生物技術有限責任公司 |
Automatic injection device, automatic injection method and method for preventing misfiring
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
AU2011210840B2
(en)
|
2010-01-27 |
2014-12-11 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
RU2015143910A
(en)
*
|
2010-02-03 |
2018-12-28 |
Инфинити Фармасьютикалз, Инк. |
FATTY ACID AMID HYDROLASE INHIBITORS
|
WO2011112635A1
(en)
|
2010-03-08 |
2011-09-15 |
Sloan-Kettering Institute For Cancer Research |
Cdc7 kinase inhibitors and uses thereof
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
KR101850687B1
(en)
|
2010-04-21 |
2018-04-20 |
애브비 바이오테크놀로지 리미티드 |
Wearable automatic injection device for controlled delivery of therapeutic agents
|
WO2011140296A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals |
Triazoles as inhibitors of fatty acid synthase
|
EP2566853B1
(en)
|
2010-05-05 |
2017-01-25 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
EP2566953B1
(en)
|
2010-05-07 |
2019-01-02 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
BR122020018186B1
(en)
|
2010-05-11 |
2021-07-27 |
Lantheus Medical Imaging, Inc |
USE OF IMAGING AGENTS TO PREPARE A COMPOSITION FOR DETECTION OF THE NOREPINEPHRIN CONVEYOR (NET) AND METHOD FOR THE DETECTION OF NET
|
ES2664872T3
(en)
|
2010-06-18 |
2018-04-23 |
Taiho Pharmaceutical Co., Ltd |
PRPK-TPRKB modulators and their uses
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
DK2603600T3
(en)
|
2010-08-13 |
2019-03-04 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES
|
EP2611922A1
(en)
|
2010-08-31 |
2013-07-10 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
US8802110B2
(en)
|
2010-09-21 |
2014-08-12 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
EP4108671A1
(en)
|
2010-10-01 |
2022-12-28 |
ModernaTX, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
BR112013007946B1
(en)
|
2010-10-04 |
2022-07-12 |
Massachusetts Institute Of Technology |
PHARMACEUTICAL AND IMMUNOGENIC COMPOSITIONS COMPRISING HEMAGGLUTININ POLYPEPTIDES
|
WO2012064973A2
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
UA115767C2
(en)
|
2011-01-10 |
2017-12-26 |
Інфініті Фармасьютікалз, Інк. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
US9089579B2
(en)
|
2011-01-19 |
2015-07-28 |
Topokine Therapeutics, Inc. |
Methods and compositions for treating metabolic syndrome
|
EP3473283B1
(en)
|
2011-01-24 |
2020-12-09 |
AbbVie Biotechnology Ltd. |
Removal of needle shields from syringes and automatic injection devices
|
WO2012103037A1
(en)
|
2011-01-24 |
2012-08-02 |
Anterios, Inc. |
Oil compositions
|
AU2012210170B2
(en)
|
2011-01-24 |
2016-09-29 |
Elcam Medical Agricultural Cooperative Association Ltd. |
Injector
|
KR20140005998A
(en)
|
2011-01-24 |
2014-01-15 |
안테리오스, 인코퍼레이티드 |
Nanoparticle compositions, formulations thereof, and uses therefor
|
DK2667854T3
(en)
|
2011-01-24 |
2019-04-23 |
Anterios Inc |
NANO PARTICLE FORMATIONS
|
EP3187216B1
(en)
|
2011-01-24 |
2019-08-21 |
AbbVie Biotechnology Ltd. |
Automatic injection devices having overmolded gripping surfaces
|
US8703818B2
(en)
|
2011-03-03 |
2014-04-22 |
Tersus Pharmaceuticals, LLC |
Compositions and methods comprising C16:1n7-palmitoleate
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
CN103533953A
(en)
|
2011-05-17 |
2014-01-22 |
葛兰素史密丝克莱恩生物有限公司 |
Vaccine against streptococcus pneumoniae
|
WO2012177997A1
(en)
|
2011-06-22 |
2012-12-27 |
The General Hospital Corporation |
Treatment of proteinopathies
|
US8496619B2
(en)
|
2011-07-15 |
2013-07-30 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
US9220660B2
(en)
|
2011-07-15 |
2015-12-29 |
Antares Pharma, Inc. |
Liquid-transfer adapter beveled spike
|
AU2012284091B2
(en)
|
2011-07-19 |
2015-11-12 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
PT2734510T
(en)
|
2011-07-22 |
2019-02-13 |
Massachusetts Inst Technology |
Activators of class i histone deacetlyases (hdacs) and uses thereof
|
WO2013032591A1
(en)
|
2011-08-29 |
2013-03-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
CA2846893A1
(en)
|
2011-09-09 |
2013-03-14 |
Greenlight Biosciences, Inc. |
Cell-free preparation of carbapenems
|
CN104159890B
(en)
|
2011-09-09 |
2018-04-10 |
蓝瑟斯医学影像公司 |
Composition, method and system for synthesizing and using developer
|
EP2755693A4
(en)
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
Engineered nucleic acids and methods of use thereof
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
CN103974724B
(en)
|
2011-10-03 |
2019-08-30 |
现代泰克斯公司 |
Nucleosides, nucleotide and nucleic acid of modification and application thereof
|
US9096684B2
(en)
|
2011-10-18 |
2015-08-04 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP6106685B2
(en)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
Inhibitors of C-JUN-N-terminal kinase (JNK)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CA2859387A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
WO2013090750A1
(en)
|
2011-12-16 |
2013-06-20 |
University Of Florida Research Foundation, Inc. |
Uses of 4'-desferrithiocin analogs
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
AU2013221432B2
(en)
|
2012-02-15 |
2018-01-18 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
WO2013152277A2
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP2850091A1
(en)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
EP2850090B1
(en)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
KR20150011346A
(en)
|
2012-04-06 |
2015-01-30 |
안타레스 팔마, 인코퍼레이티드 |
Needle assisted jet injection administration of testosterone compositions
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
EP2841098A4
(en)
|
2012-04-23 |
2016-03-02 |
Allertein Therapeutics Llc |
Nanoparticles for treatment of allergy
|
WO2013169800A1
(en)
|
2012-05-07 |
2013-11-14 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
KR102122618B1
(en)
|
2012-05-10 |
2020-06-29 |
메사츄세츠 인스티튜트 어브 테크놀로지 |
Agents for influenza neutralization
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
WO2014024026A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
JP6302909B2
(en)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
Cell-permeable probes for sialidase identification and imaging
|
CA3113959A1
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
RS58700B1
(en)
|
2012-10-12 |
2019-06-28 |
Broad Inst Inc |
Gsk3 inhibitors and methods of use thereof
|
WO2014063068A1
(en)
|
2012-10-18 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
CN105102000B
(en)
|
2012-11-01 |
2021-10-22 |
无限药品公司 |
Cancer therapy using PI3 kinase subtype modulators
|
MX2015005244A
(en)
|
2012-11-01 |
2015-07-14 |
Aileron Therapeutics Inc |
Disubstituted amino acids and methods of preparation and use thereof.
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
EP2922542A4
(en)
|
2012-11-21 |
2016-10-05 |
Topokine Therapeutics Inc |
Methods and compositions for locally increasing body fat
|
JP6144355B2
(en)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
Chemically modified mRNA
|
US9775915B2
(en)
|
2012-11-26 |
2017-10-03 |
President And Fellows Of Harvard College |
Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
|
US9908887B2
(en)
|
2012-12-21 |
2018-03-06 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
EP2935222B1
(en)
|
2012-12-21 |
2018-09-05 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
US9365555B2
(en)
|
2012-12-21 |
2016-06-14 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
JP2016505002A
(en)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
PRMT5 inhibitors containing dihydroisoquinoline or tetrahydroisoquinoline and uses thereof
|
WO2014113089A2
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
US20140335504A1
(en)
|
2013-02-07 |
2014-11-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
EP2953638B1
(en)
|
2013-02-07 |
2023-07-05 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
CA2900672C
(en)
|
2013-02-11 |
2018-03-27 |
Antares Pharma, Inc. |
Needle assisted jet injection device having reduced trigger force
|
JP6030803B2
(en)
|
2013-03-11 |
2016-11-24 |
アンタレス・ファーマ・インコーポレーテッド |
Dose syringe with pinion system
|
EP2991665A4
(en)
|
2013-03-13 |
2016-11-09 |
Harvard College |
Stapled and stitched polypeptides and uses thereof
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
WO2014151386A1
(en)
|
2013-03-15 |
2014-09-25 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
EP3760223A1
(en)
|
2013-04-03 |
2021-01-06 |
N-Fold Llc |
Nanoparticle composition for desensitizing a subject to peanut allergens
|
US9982005B2
(en)
|
2013-04-04 |
2018-05-29 |
President And Fellows Of Harvard College |
Macrolides and methods of their preparation and use
|
ES2774330T3
(en)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Drug supply polymer and uses thereof
|
US10301359B2
(en)
|
2013-04-30 |
2019-05-28 |
Massachusetts Institute Of Technology |
Human adaptation of H3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(en)
|
2013-05-10 |
2018-06-16 |
|
|
RU2705204C2
(en)
|
2013-05-30 |
2019-11-06 |
Инфинити Фармасьютикалз, Инк. |
Treating malignant tumors using piz-kinase isoform modulators
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
JP6469661B2
(en)
|
2013-06-11 |
2019-02-13 |
カラ ファーマシューティカルズ インコーポレイテッド |
Urea derivatives and uses thereof
|
KR20160019547A
(en)
|
2013-06-14 |
2016-02-19 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Stabilized polypeptide insulin receptor modulators
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
BR112016001457A2
(en)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
TRANSCRIPTION FACTOR INHIBITORS AND THEIR USES
|
WO2015021058A2
(en)
|
2013-08-05 |
2015-02-12 |
Greenlight Biosciences, Inc. |
Engineered proteins with a protease cleavage site
|
CN105555304A
(en)
|
2013-08-05 |
2016-05-04 |
葛兰素史密丝克莱恩生物有限公司 |
Combination immunogenic compositions
|
CN105682666B
(en)
|
2013-09-06 |
2021-06-01 |
中央研究院 |
Activation of human iNKT cells using glycolipids
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TWI657085B
(en)
|
2013-10-04 |
2019-04-21 |
英菲尼提製藥股份有限公司 |
Heterocyclic compounds and uses thereof
|
US9982009B2
(en)
|
2013-10-15 |
2018-05-29 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
CA2927917C
(en)
|
2013-10-18 |
2022-08-09 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of proliferative diseases
|
WO2015058140A1
(en)
|
2013-10-18 |
2015-04-23 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2015061204A1
(en)
|
2013-10-21 |
2015-04-30 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US9458169B2
(en)
|
2013-11-01 |
2016-10-04 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
AU2014369834B2
(en)
|
2013-12-24 |
2018-12-20 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
EP3094352B1
(en)
|
2014-01-16 |
2020-09-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
EP3119415A4
(en)
|
2014-03-07 |
2017-11-29 |
The Arizona Board of Regents on behalf of the University of Arizona |
Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
|
JP6701088B2
(en)
|
2014-03-19 |
2020-05-27 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Heterocyclic compounds for use in the treatment of PI3K-gamma mediated disorders
|
EP3129767B1
(en)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
US10293035B2
(en)
|
2014-03-28 |
2019-05-21 |
University Of Washington Through Its Center For Commercialization |
Breast and ovarian cancer vaccines
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
WO2015168380A1
(en)
|
2014-04-30 |
2015-11-05 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
JP6759109B2
(en)
|
2014-05-21 |
2020-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
RAS inhibitory peptides and their use
|
TWI717319B
(en)
|
2014-05-27 |
2021-02-01 |
中央研究院 |
Fucosidase from bacteroides and methods using the same
|
TWI679020B
(en)
|
2014-05-27 |
2019-12-11 |
中央研究院 |
Anti-her2 glycoantibodies and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
KR20170003720A
(en)
|
2014-05-27 |
2017-01-09 |
아카데미아 시니카 |
Anti-cd20 glycoantibodies and uses thereof
|
KR102494193B1
(en)
|
2014-05-28 |
2023-01-31 |
아카데미아 시니카 |
Anti-tnf-alpha glycoantibodies and uses thereof
|
CA2951430A1
(en)
|
2014-06-13 |
2015-12-17 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
CR20170011A
(en)
|
2014-06-19 |
2017-04-04 |
Ariad Pharma Inc |
HETEROARILO COMPOUNDS FOR INHIBITION OF CINASA
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
WO2016011386A1
(en)
|
2014-07-18 |
2016-01-21 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
CN107001404B
(en)
|
2014-09-08 |
2021-06-29 |
中央研究院 |
Activation of human iNKT cells using glycolipids
|
WO2016049359A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
MX2017003819A
(en)
|
2014-09-24 |
2017-06-15 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof.
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
EA035145B1
(en)
|
2014-10-21 |
2020-05-06 |
Ариад Фармасьютикалз, Инк. |
Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine
|
US20180015101A1
(en)
|
2014-10-28 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
EP3461904A1
(en)
|
2014-11-10 |
2019-04-03 |
ModernaTX, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
EP3230272B1
(en)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
AU2015371251B2
(en)
|
2014-12-23 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
AU2015369707B2
(en)
|
2014-12-23 |
2020-07-23 |
Sloan-Kettering Institute For Cancer Research |
Polymorph of granaticin B
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
JP6779887B2
(en)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカAcademia Sinica |
New glycan conjugate and how to use it
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
WO2016160617A2
(en)
|
2015-03-27 |
2016-10-06 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
JP6843065B2
(en)
|
2015-03-30 |
2021-03-17 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
Cell-free production of ribonucleic acid
|
AU2016255770A1
(en)
|
2015-04-27 |
2017-11-16 |
University Of Florida Research Foundation, Incorporated |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
CA2990172A1
(en)
|
2015-06-19 |
2016-12-22 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP7028766B2
(en)
|
2015-09-09 |
2022-03-02 |
ダナ-ファーバー キャンサー インスティテュート, インコーポレイテッド |
Inhibitor of cyclin-dependent kinase
|
CN108368161A
(en)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
Peptidomimetic macrocyclic compound as MCL-1 conditioning agents
|
LT3350157T
(en)
|
2015-09-17 |
2022-02-25 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
DK3350333T3
(en)
|
2015-09-17 |
2022-01-31 |
Modernatx Inc |
POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION
|
WO2017059389A1
(en)
|
2015-10-01 |
2017-04-06 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JP7114465B2
(en)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
Compounds and compositions for intracellular delivery of drugs
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
CR20180525A
(en)
|
2016-04-06 |
2019-02-14 |
Greenlight Biosciences Inc |
RIBONUCLEIC ACID PRODUCTION FREE OF CELLS
|
US11116832B2
(en)
|
2016-06-03 |
2021-09-14 |
Sanofi Pasteur Inc. |
Modification of engineered influenza hemagglutinin polypeptides
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
AU2017286606A1
(en)
|
2016-06-14 |
2018-12-13 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
MX2019001341A
(en)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition.
|
JP7001687B2
(en)
|
2016-08-05 |
2022-02-04 |
サノフィ パスツール インコーポレイティッド |
Polyvalent pneumococcal polysaccharide-protein conjugate composition
|
JP7213549B2
(en)
|
2016-08-22 |
2023-01-27 |
シーエイチオー ファーマ インコーポレイテッド |
Antibodies, Binding Fragments, and Methods of Use
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
WO2018170336A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
RS63953B1
(en)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Compound and compositions for intracellular delivery of therapeutic agents
|
WO2018175324A1
(en)
|
2017-03-20 |
2018-09-27 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
BR112019027387A8
(en)
|
2017-06-23 |
2022-12-06 |
Univ Maryland |
IMMUNOGENIC COMPOSITIONS
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds and uses thereof
|
CA3073211A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
WO2019075167A1
(en)
|
2017-10-11 |
2019-04-18 |
Greenlight Biosciences, Inc. |
Methods and compositions for nucleoside triphosphate and ribonucleic acid production
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
US20220409536A1
(en)
|
2018-09-19 |
2022-12-29 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
EP3852728A1
(en)
|
2018-09-20 |
2021-07-28 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
WO2020150372A1
(en)
|
2019-01-16 |
2020-07-23 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
AU2020209170A1
(en)
|
2019-01-16 |
2021-08-12 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
CA3128215A1
(en)
|
2019-01-31 |
2020-08-06 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
CN114728050A
(en)
|
2019-07-31 |
2022-07-08 |
圣诺菲·帕斯图尔公司 |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of use thereof
|
US20220280639A1
(en)
|
2019-07-31 |
2022-09-08 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
WO2021097061A1
(en)
|
2019-11-13 |
2021-05-20 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
US20230285297A1
(en)
|
2020-01-31 |
2023-09-14 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
CN116710116A
(en)
|
2020-10-30 |
2023-09-05 |
Xeno-Interface株式会社 |
Beta-sheet femoral bridge peptide
|
US20230390296A1
(en)
|
2020-10-30 |
2023-12-07 |
Keio University |
Novel treatment and prevention of sarcopenia-related diseases
|
TW202237068A
(en)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
High-throughput methods for preparing lipid nanoparticles and uses thereof
|
WO2022192176A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(en)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
Compounds for treating genetic diseases
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
WO2023039108A1
(en)
|
2021-09-08 |
2023-03-16 |
Affinivax, Inc. |
Coronavirus vaccine
|
WO2023059857A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
TW202333654A
(en)
|
2021-12-16 |
2023-09-01 |
美商現代公司 |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023177579A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|